Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acellular pertussis booster immunogenicity study across age groups and countries
NL-OMON45409Phase 4Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Oct 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of Boostrix Polio in pertussis (4 cohorts), sponsored by National Institute for Public Health and the Environment. Started Oct 2017; status: active, not recruiting.
02
Drugs
Boostrix Polio
03
Conditions
pertussis
Beyond the preview
Go deeper on NL-OMON45409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45409.